Concomitant gastrin and ERBB2 gene amplifications at 7q12-q21 in the intestinal type of gastric cancer

被引:0
|
作者
Vidgren, V
Varis, A
Kokkola, A
Monni, O
Puolakkainen, P
Nordling, S
Forozan, F
Kallioniemi, A
Vakkari, ML
Kivilaakso, E
Knuutila, S
机构
[1] Univ Helsinki, Cent Hosp, Mol Genet Lab, FIN-00029 Helsinki, Finland
[2] Univ Helsinki, Dept Med Genet, Haartman Inst, Helsinki, Finland
[3] Univ Helsinki, Cent Hosp, Dept Surg 2, FIN-00029 Helsinki, Finland
[4] Univ Helsinki, Haartman Inst, Dept Pathol, Helsinki, Finland
[5] NIH, Natl Human Genome Res Inst, Canc Genet Lab, Bethesda, MD USA
来源
GENES CHROMOSOMES & CANCER | 1999年 / 24卷 / 01期
关键词
D O I
10.1002/(SICI)1098-2264(199901)24:1<24::AID-GCC4>3.0.CO;2-H
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Our recent studies using comparative genomic hybridization showed that gain or amplification at the 17q12-q21 region is very common in the intestinal type of gastric cancer. Here, we describe a fluorescence in situ hybridization study with gastrin (GAS)-specific and ERBB2-specific probes on ten specimens of gastric carcinoma that, by using comparative genomic hybridization, showed I) DNA copy number gain or amplification at 17q12-q21,a region known to harbor the GAS and ERBB2 genes (four cases); 2) gain of the entire chromosome 17 (three cases); or 3) normal copy number of chromosome 17 (three cases). GAS and ERBB2 protein expression was studied by Western immunoblotting from gastric canter cell lines with or without gain at 17q12-q21 as well as a breast cancer cell line with ERBB2 amplification. Our results showed that simultaneous amplification of both GAS and ERBB2 was four- to ninefold in the tumors with the 17q12-q21 amplification. Both genes were amplified in the same nuclei, and the hybridization signals were localized to the same region of the nucleus. Overexpression of GAS and ERBB2 was observed by Western immunoblotting only in the gastric cancer cell line with gain at 17q12-q21. The ERBB2 amplification is also a recurrent change in breast cancer. To investigate whether the GAS amplification is unique in gastric cancer, Fluorescence in situ hybridization analysis was performed on 40 breast cancer cell lines. The ERBB2 amplification was observed in 11 cell lines, but none of the lines showed the GAS amplification. This indicates that the formation of an amplicon, in which both the GAS and the ERBB2 genes are amplified, might be unique in gastric cancer, especially in its intestinal type, and that simultaneous amplification of both genes is important to the tumorigenesis of intestinal gastric cancer. We demonstrate here for the first time that a gene of a physiological hormone is amplified in tumors that originate from cells that normally secrete the hormone. Genes Chromosomes Cancer 24:24-29, 1999. (C) 1999 Wiley-Liss, Inc.
引用
收藏
页码:24 / 29
页数:6
相关论文
共 50 条
  • [21] THE ASSESSMENT OF ERBB2 GENE OVER EXPRESSION IN RESPECTABLE GASTRIC CANCER AND ITS RELATIONSHIP WITH HISTOPATHOLOGY SUBTYPE, GRADING AND STAGE OF DISEASE
    Makhdoumi, Yasha
    Kermani, Ali Taghizadeh
    Delgosha, Mehrdad Soltani
    Nikpour, Shafagh
    ANNALS OF ONCOLOGY, 2011, 22 : v41 - v41
  • [22] LOH at the APC/MCC gene (5Q21) in gastric cancer and preneoplastic lesions - Prognostic implications
    SanzOrtega, J
    SanzEsponera, J
    Caldes, T
    delaConcha, EG
    Sobel, ME
    Merino, MJ
    PATHOLOGY RESEARCH AND PRACTICE, 1996, 192 (12) : 1206 - 1210
  • [23] Amplification of 17q12-21 in sporadic gastric carcinomas but not in gastric carcinoma from patients with hereditary nonpolyposis colorectal cancer
    Aarnio, M
    Kokkola, A
    Puolakkainen, P
    Larramendy, ML
    El-Rifail, W
    Monni, O
    Kivilaakso, E
    Knuutila, S
    GASTROENTEROLOGY, 1998, 114 (04) : A554 - A554
  • [24] Genetic and pathologic significance of 1p, 17p, and 18q aneusomy and the ERBB2 gene in colorectal cancer and related normal colonic mucosa
    Cianciulli, A
    Cosimelli, M
    Marzano, R
    Merola, R
    Piperno, G
    Sperduti, I
    de la Iglesia, F
    Leonardo, G
    Graziano, F
    Mancini, R
    Guadagni, F
    CANCER GENETICS AND CYTOGENETICS, 2004, 151 (01) : 52 - 59
  • [25] BCII RFLP OF THE PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-2 GENE (PLANH) ON CHROMOSOME 18Q21-Q23
    YOUNG, J
    ANTALIS, TM
    CHENEVIXTRENCH, G
    NUCLEIC ACIDS RESEARCH, 1990, 18 (23) : 7196 - 7196
  • [26] Molecular characterization of HER2-negative breast cancers reveals a distinct patient subgroup with 17q12 deletion and heterozygous loss of ERBB2
    Qiu, X.
    Tarantino, P.
    Li, R.
    Grinshpun, A.
    Gupta, H.
    Hughes, M. E.
    Kirkner, G.
    Scholl, L.
    Johnson, B. E.
    Meyerson, M.
    Cherniack, A. D.
    Jiang, Y.
    Zhou, N.
    Lin, N. U.
    Long, H. W.
    Tolaney, S. M.
    Jeselsohn, R.
    ESMO OPEN, 2025, 10 (02)
  • [27] ASSIGNMENT OF THE UTEROFERRIN GENE (ACP5) TO SWINE CHROMOSOME 2Q12-]Q21 BY FLUORESCENCE IN-SITU HYBRIDIZATION
    YASUE, H
    KUSUMOTO, H
    MIKAMI, H
    CYTOGENETICS AND CELL GENETICS, 1995, 71 (03): : 249 - 252
  • [28] Fusion between the apoptosis inhibitor gene API2 and a novel 18q gene MLT, rearranged in the t(11;18)(q21;q21), marks half of the gastro-intestinal malt type lymphomas without large cell proliferation.
    Baens, M
    Maes, B
    Steyls, A
    Geboes, K
    De Wolf-Peeters, C
    Marynen, P
    Verhoef, G
    BLOOD, 1999, 94 (10) : 384A - 384A
  • [29] Construction of a gene map of the nephronophthisis type 1 (NPHP1) region on human chromosome 2q12-q13
    Nothwang, HG
    Stubanus, M
    Adolphs, J
    Hanusch, H
    Vossmerbäumer, U
    Denich, D
    Kübler, M
    Mincheva, A
    Lichter, P
    Hildebrandt, F
    GENOMICS, 1998, 47 (02) : 276 - 285
  • [30] THE GENE FOR HEREDITARY BREAST-OVARIAN CANCER, BRCA1, MAPS DISTAL TO EDH17B2 IN CHROMOSOME REGION 17Q12-Q21
    TONIN, P
    SEROVA, O
    SIMARD, J
    LENOIR, G
    FEUNTEUN, J
    MORGAN, K
    LYNCH, H
    NAROD, S
    HUMAN MOLECULAR GENETICS, 1994, 3 (09) : 1679 - 1682